Sign in Subscribe
Universities and colleges

Discordance in Melanoma Diagnosis: A Review of 392 Cases

Strategic Insights

— 1 min read

A new study examining the accuracy of melanoma diagnoses has shed light on the prevalence of discordant diagnoses among pathologists. Published in the Journal of the American Academy of Dermatology, the study revealed that a significant rate of melanoma diagnoses were found to be discordant between referring centers and a specialized dermatopathology service at the University of California, San Francisco (UCSF). The researchers re-evaluated 392 cases of thin melanoma or benign nevi diagnosed by outside dermatopathologists or surgical pathologists and found a discordance rate of 14.3%. This study highlights the importance of specialized expertise in the diagnosis of melanoma and the need for accurate and consistent histopathologic analysis.

Key Takeaways:

  • The study examined 392 cases of thin melanoma or benign nevi diagnosed by outside dermatopathologists or surgical pathologists.
  • A total of 14.3% of melanoma diagnoses were found to be discordant between referring centers and the UCSF dermatopathology service.
  • The level of discordance in the routine histopathologic interpretation of melanocytic neoplasms was found to be high.
  • The study highlights the importance of specialized expertise in the diagnosis of melanoma and the need for accurate and consistent histopathologic analysis.
  • The researchers concluded that interobserver variability in the pathological diagnosis of melanoma is a significant issue.
  • The study was conducted at the UCSF Department of Dermatology and Comprehensive Cancer Center Melanoma Center.
  • The researchers, led by B.A. Shoo, University of California, Department of Dermatology, emphasized the need for further research into the causes and consequences of discordant diagnoses.

Statistics:

  • 392 new patients with thin melanoma or benign nevi were referred to the UCSF pigmented lesion clinic during a 2-year period.
  • 14.3% of melanoma diagnoses were found to be discordant between referring centers and the UCSF dermatopathology service.
  • The study examined the cases of melanoma in situ, stage IA, and stage IB patients.

Sources:

  • B.A. Shoo, et al., "Discordance in the Histopathologic Diagnosis of Melanoma at a Melanoma Referral Center," Journal of the American Academy of Dermatology, 2010; 62(5): 751-756
  • University of California, Department of Dermatology
  • Melanoma Dermatology
  • Cancer Weekly editors
  • NewsRx.com

Read more